Successfully global eradication of polio depends four countries' efforts to vaccinate children, the Swiss-based Advisory Committee on Polio Eradication said.
The committee said most countries that experienced recent polio outbreaks are again polio-free through targeted vaccine and faster tracking methods, the World Health Organization said in a news release. In the Afghanistan, India, Nigeria and Pakistan, there is a persistent failure to vaccinate all children.
"Eradicating polio is no longer a technical issue alone. Success is now more a question of the political will to ensure effective administration at all levels so that all children get vaccine," said Stephen Cochi, ACPE chairman and senior adviser to the Director of the Global Immunization Division at the national Centers for Disease Control and Prevention in Atlanta.
The four countries should set realistic target dates for stopping polio transmission, WHO said, adding that improvements in vaccinating all children in these areas has been incremental.
ACPE estimated that it would take more than a year for Afghanistan, India, Nigeria and Pakistan to end polio.
The global eradication initiative is spearheaded by WHO, national governments, Rotary International, the CDC and UNICEF.
Copyright 2006 by United Press International
Related stories:
Somalia free of polio once again
The World Health Organization said Somalia is once again polio-free thanks to the efforts of 10,000 health workers and volunteers.
Most vaccine-allergic children can still be safely vaccinated, experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center. Writing in the September issue of
Pediatrics, the multicenter research team offers pediatricians a step-by-step tool for quickly identifying children with allergic reactions to vaccines, and a much-needed guide, they say, to safely immunize those who are allergic.
Parents follow pediatrician advice on administering MMR vaccinations
News stories about an allegedly harmful link between the mumps, measles and rubella vaccine and the onset of autism had little effect on whether U.S. parents immunized their children, according to a review of immunization records and news stories. Parents’ decisions were more likely influenced by recommendations from their child’s pediatrician, the researchers said.
Removing barriers to the distribution of life-saving vaccines
Barriers to the distribution of life saving vaccines in low income countries can and should be overcome, say experts in this week’s issue of the BMJ.
Polio's eradication still uncertain
Efforts to wipe out polio have stalled in recent years and eradication of the crippling disease remains a question mark, U.S. and world experts say.
New treatments for viral and other diseases by blocking genes
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
Scientists see Norwalk virus' Achilles heel
Using the Canadian Light Source synchrotron, an international team led by University of Calgary researcher Ken Ng has determined the detailed structure of the enzyme the Norwalk virus uses to make copies of its genetic code in order to replicate itself. The information is crucial to developing drugs that could be used to treat outbreaks of Norwalk and other related viruses.
Combination vaccine protects monkeys from ebola and Marburg viruses
An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. Researchers from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) report their results today (Feb. 26) at the 2008 ASM Biodefense and Emerging Diseases Research Meeting in Baltimore, MD.